Managed Markets
About Managed Markets
The Managed Markets Service provides benchmark intelligence into the commercial and government payer landscape, including evolving market trends, stakeholder perspectives, and manufacturer engagement across four key segments. Insights help pharmaceutical teams better understand the factors influencing market access, pricing, utilization, and customer decision-making. The service also examines organizational structures within pharma managed markets teams.
Latest Research Insights
For more information, or to subscribe, contact:
(408) 884-8560
Research Archive
2026 Research
Medicare Advantage Plans: Market Landscape Trends, Contracting Environment and Manufacturer Engagement
August 2026. Examines the current Medicare Advantage market landscape, market trends, and contracting environment, and reviews Medicare Advantage executives' evaluation of manufacturers' willingness to contract and quality of programs/resources, and identifies partnership opportunities.
Pharmacy Benefit Managers: Market Landscape and Strategic Imperatives
April 2026: Examines the current market landscape, PBM executives' strategic imperatives going forward, and views on market trends that could impact the segment further.
Commercial Health Plans: Market Landscape and Strategic Imperatives
May 2026. Examines the current market landscape, health plan executives’ strategic imperatives going forward, and views on market trends that could impact the segment further.
Commercial Health Plans: Contracting Landscape and Manufacturer Competitive Assessment
March 2026. Reviews the commercial health plan contracting landscape and pharmacy and medical directors’ evaluation of manufacturers willingness to contract.
Pharmacy Benefit Managers: Contracting Landscape and Manufacturer Competitive Assessment
February 2026. Examines the PBM contracting landscape and PBM key decision-makers’ evaluation of manufacturers willingness to contract.
Managed Markets Headcount & Organization Study
January 2026. Assists pharmaceutical manufacturers in understanding trends in headcounts across very large, large, and mid-size firms.
Market Access and Partnership Landscape
January 2026. Provides pharmaceutical firms’ ratings of key Pharmacy Benefit Manager, PBM-owned GPO, Managed Care Organization, and Medical Benefits Manager accounts in ability to limit brand access and willingness to partner with manufacturers. Examines respondents’ rationales driving ratings.
2025 Research
Medicaid MCOs: Market Trends, Contracting Environment and Manufacturer Engagement
December 2025. Examines the Medicaid MCO market landscape, current contracting landscape, reviews Medicaid MCO executives’ evaluation of manufacturer engagement, and identifies partnership opportunities.
Medicare Advantage Plans: Market Landscape Trends, Contracting Environment and Manufacturer Engagement
Commercial Health Plans: Market Landscape and Strategic Imperatives
Pharmacy Benefit Managers: Market Landscape and Strategic Imperatives
Commercial Health Plans: Contracting Landscape and Manufacturer Competitive Assessment
Pharmacy Benefit Managers: Contracting Landscape and Manufacturer Competitive Assessment
Managed Markets Headcount & Organization Study 2025/2026
Market Access and Partnership Landscape: Key PBM Accounts
Medicaid MCOs: Market Landscape Trends, Contracting Environment and Manufacturer Engagement
Go Deeper:
Managed Markets
Healthcare market trends continue to shape the environment in which pharmaceutical manufacturers and healthcare stakeholders operate. For more than 35 years, HIRC’s Managed Markets Service has monitored the market dynamics influencing pharmaceutical access, pricing, and customer engagement, providing independent insights into the perspectives, priorities, and challenges facing key payer segments.
The service helps pharmaceutical teams better understand evolving stakeholder needs and make more informed strategic decisions regarding market access, customer engagement, and organizational planning.
For more information or to subscribe, contact Josh Mader via email.
HIRC employs a triangulated research methodology that combines primary survey research, in-depth stakeholder interviews, and secondary market analysis to provide a comprehensive understanding of healthcare stakeholder perspectives, market dynamics, and emerging industry trends.
Research includes commercial pharmacy and medical directors, PBM leaders, Medicaid MCO executives, Medicare Advantage leaders, and pharmaceutical manufacturers as follows:
- Pharmaceutical Manufacturers: Managed Markets Headcounts and Organizational Study
- Pharmaceutical Manufacturers: Access and Partnership Landscape for Key Accounts
- Market: Commercial Health Plans
- Market: Commercial PBMs
- Market: Medicare Advantage Plans
- Market: Medicaid MCOs
Subscribers can benchmark manufacturer resources and engagement, monitor payer priorities, understand evolving market dynamics, and make more informed decisions regarding market access strategy, customer engagement, and organizational planning.